Acute and chronic viral hepatitis revisited

Area of Science:

• Hepatology
• Infectious Diseases
• Vaccinology

Background:

• Hepatitis A is an acute, fecal-transmitted illness without chronicity, preventable by gamma immunoglobulin and future vaccines.
• Hepatitis B is a global blood-borne pathogen causing chronic hepatitis, cirrhosis, and liver cancer, with high prevalence in specific regions and populations.
• Non-A, non-B hepatitis is diagnosed by exclusion, lacking specific tests or therapies, and likely comprises multiple viral types.

Purpose of the Study:

• To differentiate the characteristics and management strategies for Hepatitis A, Hepatitis B, and Non-A, non-B hepatitis.
• To highlight the preventative measures and treatment considerations for different types of viral hepatitis.
• To underscore the public health significance and global impact of Hepatitis B infection.

Main Methods:

• Review of existing literature on viral hepatitis epidemiology, transmission, and clinical outcomes.
• Analysis of preventative strategies including immunoglobulin and vaccination.
• Discussion of therapeutic approaches for chronic Hepatitis B based on disease stage.

Main Results:

• Hepatitis A: acute, fecal-spread, no chronicity, preventable.
• Hepatitis B: blood-borne, chronic potential (cirrhosis, cancer), vaccine available, specific treatment based on 'e' antigen status.
• Non-A, non-B hepatitis: diagnosis of exclusion, no specific test/therapy, at least four subtypes identified.

Conclusions:

• Hepatitis A and B are distinct viral infections requiring different management and prevention strategies.
• Vaccination is a key strategy for preventing Hepatitis B, especially for high-risk infants.
• Further research is needed for Non-A, non-B hepatitis due to diagnostic and therapeutic limitations.